21.11.17|Lilach BaumerThe Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange
24.09.17|Golan HazaniThe deal discussed gives Super-Pharm a $540 million value. The Israel drugstore chain operates in markets complementing CVC’s acquisition of Zabaka Polska